Battered by higher prescription drug costs and increased patient use of medical services, Highmark Health swung into the red in 2024, with an operating loss of $209 million on $29.4 billion in operating revenue.
The red ink reflects an industry trend, with both Blues and other insurance carriers reporting operating losses in 2024. Highmark’s loss came despite a $2.3 billion or 9% increase in operating revenue when compared to 2023.
Last year’s results mean the diversified Downtown-based insurer and hospital network had a 2024 loss of $209 million and a year-over-year margin loss of $547 million.
“The broader Blues system is not immune to these changes,” CFO Carl Daley said, citing steep yearend losses reported at Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and other Blues insurers. “We expect these financial headwinds to continue.”
Highmark’s health plans, which includes Blue Cross Blue Shield health insurance, reported an operating revenue increase of $1.5 billion or 7.3% to $22 billion, while the operating loss was $166 million, for a year-over-year decrease of $562 million.
At the Allegheny Health Network health system, operating revenue rose 8.9% to $5.1 billion while its operating loss was $147 million.
Read More
That represents a 9% improvement from the $172.7 million loss in 2023. Inpatient and outpatient registrations, physician visits and emergency room visits all rose.
In the fourth quarter, AHN’s operating loss was steeper — $62.4 million versus $9.2 million for the same three months in 2023.
Highmark and several of the other Blues plans blamed last year’s losses on rapidly rising health care costs, increased use of medical services by patients — particularly among Medicare Advantage plan members — and sharply higher prescription drug costs, especially for specialty medications and GLP-1 drugs used to treat diabetes and weight management.
Highmark Health President and CEO David Holmberg said the company is pioneering a new approach to health care, which is targeted to help rein in costs.
“Our industry needs a more economically sustainable approach that delivers better health experiences and outcomes,” he said in a prepared statement. “That is exactly the challenge we’ve taken on with our long-term transformational strategy and Living Health model,” which is a value-based, shared risk model.
“We’re built for this and ready to go,” he said in a conference call Thursday.
Highmark’s United Concordia dental services and HM Insurance Group, which sells stop-loss coverage, each delivered steady results in 2024.
Operating revenue for United Concordia increased about $100 million to $1.7 billion in 2024, while the operating margin was essentially flat from 2023 to 2024 at $105 million.
HM Insurance reported a 21% increase in operating revenue to $1.2 billion from $1 billion in 2023 while the margin for the unit rose to $56 million from $55 million in 2023.
Highmark’s information technology service for commercial insurers, enGen, reported $1.2 billion in operating revenue for 2024, essentially flat since 2023. Highmark does not disclose enGen’s operating margins.
At the end of March, health care industry veteran Mark Sevco takes over as the third AHN president in two years. He replaces Jim Benedict who was named president in 2023.
Most recently, Mr. Sevco was COO at Sacramento-based Sutter Health, which operates 24 hospitals. He also served in executive roles at Pittsburgh-based UPMC for 28 years before leaving for Sutter.






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.